Cargando…
Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis
We have recently developed a sensitive and specific urine‐based antigen detection ELISA for the diagnosis of visceral leishmaniasis (VL). This assay used rabbit IgG and chicken IgY polyclonal antibodies specific for the Leishmania infantum proteins iron superoxide dismutase 1 (Li‐isd1), tryparedoxin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220836/ https://www.ncbi.nlm.nih.gov/pubmed/30120856 http://dx.doi.org/10.1111/pim.12584 |
_version_ | 1783368898718990336 |
---|---|
author | Abeijon, Claudia Dilo, Julia Tremblay, Jacqueline M. Viana, Agostinho G. Bueno, Lilian L. Carvalho, Silvio F. G. Fujiwara, Ricardo T. Shoemaker, Charles B. Campos‐Neto, Antonio |
author_facet | Abeijon, Claudia Dilo, Julia Tremblay, Jacqueline M. Viana, Agostinho G. Bueno, Lilian L. Carvalho, Silvio F. G. Fujiwara, Ricardo T. Shoemaker, Charles B. Campos‐Neto, Antonio |
author_sort | Abeijon, Claudia |
collection | PubMed |
description | We have recently developed a sensitive and specific urine‐based antigen detection ELISA for the diagnosis of visceral leishmaniasis (VL). This assay used rabbit IgG and chicken IgY polyclonal antibodies specific for the Leishmania infantum proteins iron superoxide dismutase 1 (Li‐isd1), tryparedoxin1 (Li‐txn1) and nuclear transport factor 2 (Li‐ntf2). However, polyclonal antibodies have limitations for upscaling and continuous supply. To circumvent these hurdles, we began to develop immortalized monoclonal antibodies. We opted for recombinant camelid VHHs because the technology for their production is well established and they do not have Fc, hence providing less ELISA background noise. We report here an assay development using VHHs specific for Li‐isd1 and Li‐ntf2. This new assay was specific and had analytical sensitivity of 15‐45 pg/mL of urine. The clinical sensitivity was comparable to that obtained with the ELISA assembled with conventional rabbit and chicken antibodies to detect these two antigens. Therefore, similar to our former studies with conventional antibodies, the future inclusion of VHH specific for Li‐txn1 and/or other antigens should further increase the sensitivity of the assay. These results confirm that immortalized VHHs can replace conventional antibodies for the development of an accurate and reproducible antigen detection diagnostic test for VL. |
format | Online Article Text |
id | pubmed-6220836 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62208362018-11-13 Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis Abeijon, Claudia Dilo, Julia Tremblay, Jacqueline M. Viana, Agostinho G. Bueno, Lilian L. Carvalho, Silvio F. G. Fujiwara, Ricardo T. Shoemaker, Charles B. Campos‐Neto, Antonio Parasite Immunol Original Articles We have recently developed a sensitive and specific urine‐based antigen detection ELISA for the diagnosis of visceral leishmaniasis (VL). This assay used rabbit IgG and chicken IgY polyclonal antibodies specific for the Leishmania infantum proteins iron superoxide dismutase 1 (Li‐isd1), tryparedoxin1 (Li‐txn1) and nuclear transport factor 2 (Li‐ntf2). However, polyclonal antibodies have limitations for upscaling and continuous supply. To circumvent these hurdles, we began to develop immortalized monoclonal antibodies. We opted for recombinant camelid VHHs because the technology for their production is well established and they do not have Fc, hence providing less ELISA background noise. We report here an assay development using VHHs specific for Li‐isd1 and Li‐ntf2. This new assay was specific and had analytical sensitivity of 15‐45 pg/mL of urine. The clinical sensitivity was comparable to that obtained with the ELISA assembled with conventional rabbit and chicken antibodies to detect these two antigens. Therefore, similar to our former studies with conventional antibodies, the future inclusion of VHH specific for Li‐txn1 and/or other antigens should further increase the sensitivity of the assay. These results confirm that immortalized VHHs can replace conventional antibodies for the development of an accurate and reproducible antigen detection diagnostic test for VL. John Wiley and Sons Inc. 2018-09-11 2018-11 /pmc/articles/PMC6220836/ /pubmed/30120856 http://dx.doi.org/10.1111/pim.12584 Text en © 2018 The Authors. Parasite Immunology Published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Abeijon, Claudia Dilo, Julia Tremblay, Jacqueline M. Viana, Agostinho G. Bueno, Lilian L. Carvalho, Silvio F. G. Fujiwara, Ricardo T. Shoemaker, Charles B. Campos‐Neto, Antonio Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis |
title | Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis |
title_full | Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis |
title_fullStr | Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis |
title_full_unstemmed | Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis |
title_short | Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis |
title_sort | use of vhh antibodies for the development of antigen detection test for visceral leishmaniasis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220836/ https://www.ncbi.nlm.nih.gov/pubmed/30120856 http://dx.doi.org/10.1111/pim.12584 |
work_keys_str_mv | AT abeijonclaudia useofvhhantibodiesforthedevelopmentofantigendetectiontestforvisceralleishmaniasis AT dilojulia useofvhhantibodiesforthedevelopmentofantigendetectiontestforvisceralleishmaniasis AT tremblayjacquelinem useofvhhantibodiesforthedevelopmentofantigendetectiontestforvisceralleishmaniasis AT vianaagostinhog useofvhhantibodiesforthedevelopmentofantigendetectiontestforvisceralleishmaniasis AT buenolilianl useofvhhantibodiesforthedevelopmentofantigendetectiontestforvisceralleishmaniasis AT carvalhosilviofg useofvhhantibodiesforthedevelopmentofantigendetectiontestforvisceralleishmaniasis AT fujiwararicardot useofvhhantibodiesforthedevelopmentofantigendetectiontestforvisceralleishmaniasis AT shoemakercharlesb useofvhhantibodiesforthedevelopmentofantigendetectiontestforvisceralleishmaniasis AT camposnetoantonio useofvhhantibodiesforthedevelopmentofantigendetectiontestforvisceralleishmaniasis |